Chatchai  Chaotham  has  completed  his  Ph.D.  study  in  2013  from  International  Graduate  Program  in  Pharmaceutical  Technology,  Faculty  of  Pharmaceutical Sciences, Chulalongkorn University, Thailand. He received his Ph.D. grant from The Royal Golden Jubilee Ph.D. Program (grant no. 5.Q.CU/50/C.1). During his doctoral degree study, he was an invited researcher under the supervision of Prof. Samuel Lundin at the Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Sweden. Now he continues his postdoctoral fellowship on cancer research at the Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand.       Chatchai  Chaotham  has  completed  his  Ph.D.  study  in  2013  from  International  Graduate  Program  in  Pharmaceutical  Technology,  Faculty  of  Pharmaceutical Sciences, Chulalongkorn University, Thailand. He received his Ph.D. grant from The Royal Golden Jubilee Ph.D. Program (grant no. 5.Q.CU/50/C.1). During his doctoral degree study, he was an invited researcher under the supervision of Prof. Samuel Lundin at the Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Sweden. Now he continues his postdoctoral fellowship on cancer research at the Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand.      

Pharmaceutical Sciences and Toxicology